Companies / Genocea Biosciences, Inc.
Genocea Biosciences, Inc.
GNCACIK 1457612
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 24, 2022 | Walker Paul Edward 10% owner | Sell Open-market sale | Common Stock | $387.9K | -5.9M -57.16% | 4,445,093 | medium |
| May 24, 2022 | Sonsini Peter W. 10% owner | Sell Open-market sale | Common Stock | $387.9K | -5.9M -57.16% | 4,445,093 | medium |
| May 24, 2022 | Sandell Scott D 10% owner | Sell Open-market sale | Common Stock | $387.9K | -5.9M -57.16% | 4,445,093 | medium |
| May 24, 2022 | New Enterprise Associates 16, L.P. 10% owner | Sell Open-market sale | Common Stock | $387.9K | -5.9M -57.16% | 4,445,093 | medium |
| May 24, 2022 | Makhzoumi Mohamad 10% owner | Sell Open-market sale | Common Stock | $387.9K | -5.9M -57.16% | 4,445,093 | medium |
| May 24, 2022 | Florence Anthony A. Jr. 10% owner | Sell Open-market sale | Common Stock | $387.9K | -5.9M -57.16% | 4,445,093 | medium |
| May 24, 2022 | Chang Carmen 10% owner | Sell Open-market sale | Common Stock | $387.9K | -5.9M -57.16% | 4,445,093 | medium |
| May 24, 2022 | Behbahani Ali Director | Sell Open-market sale | Common Stock | $387.9K | -5.9M -57.16% | 4,445,093 | medium |